BenevolentAI SA (BAI)

Amsterdam
2.46
0.00(0.00%)
  • Volume:
    3,306
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    2.42 - 2.46

BAI Overview

Prev. Close
2.46
Day's Range
2.42-2.46
Revenue
10.56M
Open
2.42
52 wk Range
2.22-10
EPS
-1.5
Volume
3,306
Market Cap
289.02M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
2,282
P/E Ratio
-1.43
Beta
-
1-Year Change
-75.05%
Shares Outstanding
117,488,722
Next Earnings Date
-
What is your sentiment on BenevolentAI?
or
Market is currently closed. Voting is open during market hours.

BenevolentAI SA Company Profile

BenevolentAI SA Company Profile

BenevolentAI société anonyme operates as a clinical-stage AI-enabled drug discovery and development company. Its BenevolentAI platform powers in-house drug pipeline of drug programs. The company’s therapeutic areas, include atopic dermatitis, ulcerative colitis, amyotrophic lateral sclerosis, glioblastoma multiforme, inflammatory bowel disease, antiviral, oncology, parkinson's disease, nonalcoholic steatohepatitis, fibrosis, inflammation, chronic kidney disease, and idiopathic pulmonary fibrosis. It has a collaboration with AstraZeneca to enhance understanding of complex disease biology and identify new targets. The company was formerly known as BenevolentAI Limited and changed its name to BenevolentAI société anonyme in April 2022. BenevolentAI société anonyme was founded in 2013 and is headquartered in London, United Kingdom.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralSellSellStrong Sell
Technical IndicatorsStrong BuyStrong BuyNeutralStrong SellStrong Sell
SummaryBuyBuyNeutralStrong SellStrong Sell